Screening LUMBAR Syndrome in Infants With Infantile Hemangiomas
ConditionLUMBAR Syndrome
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age0-10
SponsorWest China Hospital
About this trial
The objective of this study is to determine the maximal diameter threshold at which infants with lumbosacral, sacrococcygeal, perineal, gluteal, or lower-limb extending infantile hemangiomas should undergo screening for LUMBAR syndrome.
Eligibility criteria
Qualifiers
Clinically diagnosed infantile hemangioma.
Lesion located in at least one of the following regions: lumbosacral region, sacrococcygeal region, gluteal region, perineal region, perianal region, external genital region, or continuous extension to the lower limb.
Maximal lesion diameter ≥2.0 cm.
Written informed consent obtained from the parents or legal guardians.
Disqualifiers
Vascular anomaly other than infantile hemangioma, such as venous malformation, lymphatic malformation, arteriovenous malformation, or congenital hemangioma.
Previously diagnosed genetic or congenital syndrome unrelated to LUMBAR syndrome, which may independently explain the detected anomalies.
Incomplete clinical data preventing accurate measurement of lesion diameter.
Refusal of participation or refusal to complete core screening examinations.
Trial design
Treatments tested in this trial
- MRI
Treatment groups
70 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov